Other VPD studies

All Items

• ATAGI targeted review 2025: Immunisation considerations for immunocompromised people in Australia

  Xia Wang, Phoebe CM Williams, Ketaki Sharma, Helen Quinn, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Katie L Flanagan, Kristy Cooper, Benjamin W Teh, Michelle L Giles, Nigel W Crawford

• Measles epidemiology in Australia: 2014 to 2024 Erratum to Commun Dis Intell (2018) - https://doi.org/10.33321/cdi.2026.50.016

  Ms Lizzie Gorrell, Dr Benjamin G Polkinghorne, Prof. David N Durrheim

• Evaluation of Indigenous status completeness in vaccine preventable disease notification data in the NNDSS

  Frank Beard, Eva Molnar, Joanne Jackson, Kaitlyn Vette, Katrina Clark, Aditi Dey, Caitlin Swift, Stephen Lambert, Anna-Jane Glynn-Robinson, Kristine Macartney

• Australian National Enterovirus Reference Laboratory annual report, 2023

  Matthew B Kaye, Linda K Hobday, Aishah Ibrahim, Leesa Bruggink, Bruce R Thorley

• Never waste a measles outbreak

  David N Durrheim

• Measles secondary vaccine failure in a childcare setting: an outbreak report

  Donna Barnekow, Debbie Neucom, Wendy Tout, Dustylee Williams, Michael J Thomas, Sanmarié Schlebusch, Alyssa Pyke, Madisen S Roser, Isaac Tranter, Amalie Dyda, Colleen L Lau, Nicolas R Smoll

• Guidelines for the control of pertussis in Australia

  Communicable Diseases Network Australia and New Zealand

  xi, 1-46

• Guidelines for the control of measles outbreaks in Australia

  Communicable Diseases Network Australia and New Zealand

  xvii, 110

• Respiratory diphtheria in the time of Omicron

  Annabeth Simpson, Paul Douglas, Jenny Draper, Vitali Sintchenko, Zoe Cutcher, Daniel Ashton

• Pertussis notifications decline in Australia during COVID-19 non-pharmaceutical interventions, 2020–2021

  Saskia van der Kooi, Frank Beard, Aditi Dey, Peter McIntyre, Chrissy Imai, Janaki Amin

• Surveillance of adverse events following immunisation in Australia annual report, 2021

  Yuanfei Anny Huang, Catherine Glover, Lucy Deng, Kristine Macartney, Nicholas Wood, Claire Larter, Catherine Brogan, Olivia Richardson, Elspeth Kay

• The impact of the National Shingles Vaccination Program on the epidemiology of herpes zoster among adults ≥ 60 years in Victoria, Australia

  Madeleine J Marsland, Anna Glynn-Robinson, Rebecca F Gang, Janet Strachan

• ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia

  Yuanfei Anny Huang, Jean Li-Kim-Moy, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Bette Liu, Penelope Burns, Michelle Giles, Nigel Crawford

• A Measles outbreak in the Whitsundays, Queensland: the shape of things to come?

  Jeffrey N Hanna, Dorothy J Symons, Michael J Lyon

  589-591

• Effect of COVID-19 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020–2021

  Paraag Bhatt, Janet Strahan, Marion Easton, Lucinda Franklin, George Drewett

• Epidemiology of mumps outbreaks and the impact of an additional dose of MMR vaccine for outbreak control in regional Queensland, Australia, 2017–2018

  Jacina Walker, Odewumi Adegbija, Nicolas Smoll, Arifuzzaman Khan, Jordan Whicker, Heidi Carroll, Rachael Rodney Harris, Gulam Khandaker

• ATAGI 2021 Annual Statement on Immunisation Last updated: 19 September 2021

  Australian Technical Advisory Group on Immunisation, Catherine Tran, Clayton Chiu, Allen C. Cheng, Nigel W Crawford, Michelle L Giles, Kristine K Macartney, Christopher C Blyth

• Australian mumps serosurvey 2012–2013: any cause for concern?

  Cyra Patel, Frank Beard, Alexandra Hendry, Helen Quinn, Aditi Dey, Kristine Macartney, Linda Hueston, Dominic E Dwyer, Peter McIntyre

• Australia’s national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners

  Harunor Rashid, Aditi Dey, Ramesh Manocha, Mohamed Tashani, Kristine Macartney, Frank Beard

• Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia

  Peter Wnukowski-Mtonga, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Julia Brotherton, Basil Donovan, Madeline Hall, David W Smith, Karen Peterson, Sue Campbell-Lloyd, Christine Selvey, Michelle Giles, John Kaldor, Helen Marshall

• Improving the accuracy of ACIR data and increasing vaccination rates

  Thais A Miles, Linda V Granger, Colleen L Gately

• Potential use of Western Australia’s mandatory Midwives Notification System for routinely monitoring antenatal vaccine coverage

  Annette K Regan, Paul V Effler, Chloe Thomson, Donna B Mak

• Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?

  Olivia H Price, Kylie S Carville, Sheena G Sullivan

• Australian childhood immunisation coverage, 1 July 2015 and 30 June 2016 cohort, assessed as at 30 September 2016

  Alexandra J Hendry, National Centre for Immunisation Research and Surveillance

  106-108

• Public health action following an outbreak of toxigenic cutaneous diphtheria in an Auckland refugee resettlement centre

  Gary E Reynolds, Helen Saunders, Angela Matson, Fiona O'Kane, Sally A Roberts, Salvin K Singh, Lesley M Voss, Tomasz Kiedrzynski

  475-481

• Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia

  Julia ML Brotherton, Michael R Batchelor, Michelle O Bradley, Scott A Brown, Simone M Duncombe, Dennis Meijer, Lauren E Tracey, Maureen Watson, Rosalind J Webby

  197-200

• A Field study of household attack rates and the effectiveness of macrolide antibiotics in reducing household transmission of pertussis

  Janet B Terry, Christopher J Flatley, Debra J van den Berg, Geoffrey G Morgan, Marianne Trent, John A Turahui, Michelle C Greenwood, Paul W Corben, Greg J Bell

  27-33

• Public health response to a measles outbreak in a large correctional facility, Queensland, 2013

  Madhumati Chatterji, Anne M Baldwin, Rajendra Prakash, Susan A Vlack, Stephen B Lambert

  294-297

• Pertussis control in Australia - the current state of play

  Helen Quinn

  177-178

• A State-wide information campaign during a pertussis epidemic in New South Wales, 2010

  Paula J Spokes, Alexander E Rosewell, Alex S Stephens, Jeremy M McAnulty

  201-207

• Finding the ‘who’ in whooping cough: vaccinated siblings are important pertussis sources in infants 6 months of age and under

  Christina Bertilone, Tania Wallace, Linda Selvey

  195-200

• Australian vaccine preventable disease epidemiological review series: pertussis, 2006–2012

  Alexis Pillsbury, Helen E Quinn, Peter B McIntyre

  179-194

• Impacts of a measles outbreak in western Sydney on public health resources

  Kristina L Flego, Daniel A Belshaw, Vicky Sheppeard, Kathryn M Weston

  240-245

• Catching up with the catch–up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register

  Julia Brotherton, Dorota Gertig, Genevieve Chappell, Lesley Rowlands, Marion Saville

  197-201

• Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009

  Andrew Jardine, Stephen J Conaty, Chris Lowbridge, Jane Thomas, Michael Staff, Hassan Vally

  116-121

• An Evaluation of the Australian National Serosurveillance Program

  Andrew Jardine, Shelley L Deeks, Mahomed S Patel, Robert I Menzies, Gwendolyn L Gilbert, Peter B McIntyre

  29-36

• Measles status in Australia, and outbreaks in the first quarter of 2009

  Nicolee Martin, Ruth Foxwell

  225-231

• Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March–May 2006

  Vicky Sheppeard, Bradley Forssman, Mark J Ferson, Conrad Moreira, Sue Campbell-Lloyd, Dominic E Dwyer, Jeremy M McAnulty

  21-26

• Outbreak of pertussis, 1 January to 31 March 2009

  Katrina Roper

  36-37

• Pertussis in infants: how to protect the vulnerable?

  Lai-man R Chuk, Stephen B Lambert, Meryta L May, Frank H Beard, Theo P Sloots, Christine E Selvey, Michael D Nissen

  449-456

• Trends in invasive Haemophilus influenzae type b disease in Australia, 1995–2005

  Han Wang, Shelley Deeks, Amy Glasswell, Peter McIntyre

  316-325

• Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006

  Anita E Heywood, Kristine K Macartney, C Raina MacIntyre, Peter B McIntyre

  303-310

• Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group

  Helen E Quinn, Peter B McIntyre

  205-215

• Reduction in invasive meningococcal disease in Queensland: A success for immunisation

  Vicki G Slinko, Amy Sweeny

  227-232

• Composition of the Australian Influenza Vaccine for the 2007 season

  Australian Influenza Vaccine Committee

  260

• Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal

  Kathryn M Weston, Dominic E Dwyer, Mala Ratnamohan, Ken McPhie, Sau-wan Chan, James M Branley, Lisa J Allchin, Krishna P Hort

  358-365

• Composition of Australian influenza vaccine for the 2005 season

  Australian Influenza Vaccine Committee

  61

• An Outbreak of measles in Adelaide

  James E Fielding

  80-82

• The Cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use

  Stephen Lambert, Kerry-Ann O'Grady, Susan Gabriel, Robert Carter, Terry Nolan

  509-516

• Impact of Haemophilus influenzae type b (Hib) vaccination on Hib meningitis in children in Far North Queensland, 1989 to 2003

  Jeffrey N Hanna

  255-257

• What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children?

  Brynley P Hull, Peter B McIntyre

  238-243

• Age-related risk of adverse events following yellow fever vaccination in Australia

  Glenda L Lawrence, Margaret A Burgess, Robert B Kass

  244-248

• National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases

  National Centre for Immunisation Research and Surveillance

  92-95

• Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey

  Heath Kelly, Theo Karapanagiotidis

  69-73

• A resurgence of congenital rubella in Australia?

  Margaret A Burgess, Jill M Forrest, Tim Donovan

  533-535

• Rubella in Australia: can we explain two recent cases of congenital rubella syndrome?

  Heather Gidding, Margaret Young, Robyn Pugh, Margaret Burgess

  537-540

• Invasive pneumococcal disease among children in Victoria

  Min Liu, Ross Andrews, Joanne Stylianopoulos, Catherine Ferreira, Geoff Hogg, Nyree Pyper

  362-366

• Estimating immunisation coverage: is the 'third dose assumption' still valid?

  Brynley P Hull, Glenda L Lawrence, C Raina MacIntyre, Peter B McIntyre

  357-361

• Infection control and public health aspects of a case of pertussis infection in a maternity health care worker

  Bradley J McCall, Martyn Tilse, Beth Burt, Peter Watt, Mary Barnett, Joseph G McCormack

  584-586

• Surveillance of viral pathogens in Australia - varicella-zoster virus

  Paul Roche, Charlie Blumer, Jenean Spencer

  576-580